secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001104659-24-006668
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio appoints James Murphy as Interim CFO effective Jan 19, 2024
-----------------------------------------------------------------------

- James Murphy appointed Interim CFO, serving as Principal Financial and Accounting Officer.
- Murphy provides consulting services via Danforth Advisors; receives no direct compensation from Mustang.
- Murphy has served as interim CFO for public and private life science companies since 2012.
- No family relationships or material transactions exist between Murphy and Mustang's officers or directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924006668/0001104659-24-006668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465924006668/tm244143d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-006668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer